Results

Total Results: 2,110 records

Showing results for "risks".

341. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - This may subject patients to unnecessary coronary angiography and its potential risks (i.e., contrast … using traditional risk factors such as the Framingham Risk Score. … using traditional risk factors such as the Framingham Risk Score. … • Poor (high risk of bias). … DerSimonian and Laird formula.30 For dichotomous outcomes, we will calculate a pooled effect estimate of the relative

342. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - (ACS), although its invasive nature makes it less ideal in many patients because of its associated risks … harms, adverse reactions to drugs for stress tests, vascular complications (e.g., stroke) Consequences/risks … related to harms of testing (e.g., adverse reaction or allergy to contrast or stress agents) and risks … high risk, and mixed risk (or pretest risk not reported). … In addition, potential harm from use of invasive treatments (which carry specific risks) if clinical

343. Ch 11-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
     January 03, 2012 - asked in a study, as excluding prevalent users might omit long-term users (which could overlook risks … of death among the patients treated with aprotinin (estimates ranged from a relative risk of 1.32 … Sensitivity Analysis [propensity score] to a relative risk of 1.64 [traditional regression analysis … quickly calcification progresses once the process has begun.20 First, a model is developed for the relative … 11.2 plots the combination of the odds ratio between the exposure and the confounder (OREC) and the relative

344. Cancer-Pancreas Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
     September 01, 2014 - For quality, see section on risk of bias. b. … • EUS-FNA risks are due to the physical invasiveness of the procedure and primarily involve pancreatitis … • MRI risks mainly involve adverse reactions to contrast media. … EUS-FNA risks are due to the physical invasiveness of this procedure and primarily 16 involve pancreatitis … four imaging studies are not equally available at all institutions, and each study has its associated risks

345. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - United States.1 Pfizer supports the effort to ensure that credible and appropriate evidence on the risks … associated with taking glaucoma medication and how these risks are directly linked to specific patient … Thus, in Key Question 6, we recommend that AHRQ comprehensively evaluate the risks and harms associated … with OAG treatment by subpopulation These risks were evaluated as part of KQ6. … Public comment/ Pfizer Methods In addition, we suggest that AHRQ assess the severity of the risks

346. Research White Paper Patient- or Participant-Generated Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - with traditional registries, participants need to be informed clearly and transparently about the risks … of IRB reliance relationships in the context of PGRs is encouraged by PCORI’s PCORnet.90 Potential risks … A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging … /sha ring-clinical-trial-data-maximizing-benefits- minimizing-risk. … Participant-driven research: rich opportunities and real risks.

347. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - not experience the outcome of interest Statistically significant associations (odds/hazard ratios, relative … risks) merely indicate that more definitive evaluation of a new predictor is warranted. … Statistically significant associations such as HRs, relative risk, or ORs ratios indicate only that it … Assessing the value of risk predictions by using risk stratification tables. … Assessing the value of risk predictions by using risk stratification tables.

348. Prognostic Tests (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
     June 01, 2012 - not experience the outcome of interest Statistically significant associations (odds/hazard ratios, relative … risks) merely indicate that more definitive evaluation of a new predictor is warranted. … Statistically significant associations such as HRs, relative risk, or ORs ratios indicate only that it … Assessing the value of risk predictions by using risk stratification tables. … Assessing the value of risk predictions by using risk stratification tables.

349. Breast-Biopsy-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
     September 01, 2014 - of cancer, or did not provide information on baseline risk. … Assessment of Risk of Bias We assessed the risk of bias for each individual study following the Methods … Results are based on the model with risk group as a covariate. … of vasovagal reactions; however, results were reported in a way that precluded quantitation of the relative … risk.

350. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - stakeholders’ discussions centered on the anecdotal nature of the evidence regarding perioperative risks … Most of the discussion centered on the anecdotal nature of the evidence regarding the perioperative risks … The effectiveness of perioperative care was discussed as well as strategies for mitigating risks such … We set the range of relative risk reduction between 0.6 and 0.8, as the study reported a relative risk … power of 90 percent, the required total sample size (1:1 ratio in a two-arm RCT) for each value of relative

351. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
     February 01, 2023 - risk of bias domains defined in the AHRQ Methods Guide49, 50 and using an adapted version of the Risk … We will rate the risk of bias for each study by domain and overall, as low, moderate, or high risk of … Two independent reviewers will assess the risk of bias for each primary study. … outcomes; analytic methods including adjustment for confounding factors; and results (e.g., absolute and relative … risks of the outcome) favoring those that are adjusted for potential confounders rather than unadjusted

352. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol-amendment.pdf
     February 03, 2025 - risk of bias domains defined in the AHRQ Methods Guide49, 50 and using an adapted version of the Risk … We will rate the risk of bias for each study by domain and overall, as low, moderate, or high risk of … Two independent reviewers will assess the risk of bias for each primary study. … outcomes; analytic methods including adjustment for confounding factors; and results (e.g., absolute and relative … risks of the outcome) favoring those that are adjusted for potential confounders rather than unadjusted

353. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
     January 01, 2023 - with 15-20 treatments delivered over three to four weeks.2, 3 Although WBI successfully reduces the risk … Analysis of patterns of recurrence and pathology findings have supported that the area at highest risk … This highlights the need to investigate outcomes of PBI among patients with adverse risk factors. … These advancements result in improved dose homogeneity that may lower the risk for adverse events. … fractionation schedule, and planning parameters are recognized as critically important to understand the risks

354. Gastric-Cancers-Supplementary-App-D (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
     January 01, 2023 - There is low risk of bias in domain 2. … There is low risk of bias in domain 3. … There is high risk of bias in domain 5. Overall, this study has high risk of bias. … There is low risk of bias in domain 2. … There is high risk of bias in domain 5. Overall, this study has high risk of bias.

355. Making Healthcare Safer IV Rapid Review: Patient Monitoring Systems To Prevent Failure To Rescue (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
     December 01, 2024 - They found that the relative risk of a major adverse event was statistically lower (p<0.001) in the … Australian Between the Flags system) and found no significant change in response to the intervention (relative … of death 30 days post-alert was significantly reduced (relative risk 0.84, 95% CI 0.78 to 0.90, p<0.001 … increase in transfers (p=0.00154 and p=0.0356), two reported statistically significant decreases (relative … assessment”[tiab] OR “risk assessment”[mh] OR “risk classification”[tiab] OR “risk category”[tiab]

356. Breast-Cancer-Medications Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
     July 01, 2012 - Pfizer NOT pursuing FDA approval) has come out that shows that a 0.5 mg dose appears to reduce the risks … from medications to reduce risk of breast cancer? … Nine risk stratification models that predict an individual’s risk for developing breast cancer … Incidence rates/risks of gynecologic conditions Median 81 month follow- up reported Good/Good … Nine risk stratification models that predict an individual’s risk for developing breast cancer have

357. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
     January 01, 2022 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … of sedation, and potential increased risk of nausea versus placebo. … Synthetic THC is probably associated with a large increased risk of dizziness. … -point scale • SMD >0.8 • RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … risk; SMD = standardized mean difference.

358. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
     October 11, 2019 - risk) for binary outcomes? … Why not a relative risk? … There are pros and cons for odds ratio versus relative risk and there is no preferred way for sure. … Odds ratio has better statistical properties than relative risk such as being symmetrical when converting … We used the Cochrane Risk of Bias tool.

359. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
     January 01, 2024 - We will assess the risk of bias for RCTs using the Cochrane Risk of Bias 2 (ROB2) and NRSIs (including … As different outcomes and results from the same study may reflect different risks of bias (e.g., objective … yields a higher SOE rating than a set of studies at moderate or high risk of bias. … of bias is comparable to an RCT at low risk of bias. … RoB 2: a revised tool for assessing risk of bias in randomised trials.

360. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - group Intervention Group NCCN risk group Control group NCCN Risk group Cancer stage overall Cancer … risk factors stage T3aN0M0, Gleason score ≥7 (4+3), or PSA >20 ng/mL. … prostate cancer; high-risk with pelvic nodal involvement risk <15% by updated Partin Tables and negative … All patients with high-risk disease were prescribed ADT for 2 years. … (LR), favorable-intermediate risk (FIR), unfavorable intermediate risk (UIR) and high risk (HR) as per